Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

US Patent 9945875 · Granted Apr 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2025
Pancreatic cancer biomarkers and uses thereof2021
Cardiovascular risk event prediction and uses thereof2020
Aptamers and diagnostic methods for detecting the EGF receptor2020
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2019
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2019
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2019
Aptamers and diagnostic methods for detecting the EGF receptor2017
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2017
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2017
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2017
Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof2016